
Tazodip 4gm/0.5gm Injection
Marketer
Daksh Pharma Pvt Ltd
Salt Composition
Piperacillin (4gm) + Tazobactum (0.5gm)
Overview Tazodip 4gm/0.5gm Injection
The dual-antibiotic injection, Tazodip (4gm/0.5gm), combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by your physician based on your condition. Always adhere strictly to prescribed usage. Potential side effects include nausea, vomiting, diarrhea, and skin rash; injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, inform your doctor of any antibiotic allergies, kidney, or liver issues; dosage adjustments or alternative medications may be necessary. Under medical guidance, Tazodip is generally deemed safe for use during pregnancy and breastfeeding.
Uses of Tazodip 4gm/0.5gm Injection
Infections caused by bacteria
Major Benefits of Tazodip 4gm/0.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Tazodip 4gm/0.5gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazodip 4gm/0.5gm Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Tazodip 4gm/0.5gm Injection works:
The injectable formulation, Tazodip (4g piperacillin/0.5g tazobactam), combines the antibiotic piperacillin with the beta-lactamase inhibitor tazobactam. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Tazodip 4gm/0.5gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Tazodip (4gm/0.5gm) is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; clinical data from human subjects, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
The intravenous administration of Tazodip (4gm/0.5gm) is considered safe for breastfeeding mothers. Research in humans indicates minimal transfer of the medication into breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Tazodip 4gm/0.5gm Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Tazodip 4gm/0.5gm Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazodip 4gm/0.5gm Injection in individuals with hepatic impairment appears to pose minimal risk. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Tazodip 4gm/0.5gm Injection :
Omitting a scheduled dose of Tazodip 4gm/0.5gm Injection necessitates contacting your physician.
Facts to Know About Tazodip 4gm/0.5gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
